Nabriva Therapeutics (NBRV) Priced

Developing a novel antibiotic for bacterial pneumonia.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $10.82 0.00 (0.0%)
First Day Return 29.2%
Return from IPO 5.6%
 
Nabriva Therapeutics IPO News more
  • .
IPO Data
IPO File Date 06/18/2015
Offer Price $10.25
Price Range $10.50 - $10.50
Offer Shares (mm) 9.0
Deal Size ($mm) 92
 
IPO Data
IPO Date 09/17/2015
Offer Price $10.25
Price Range $10.50 - $10.50
Offer Shares (mm) 9.0
Deal Size ($mm) $92
 
Underwriters
more
Business Overview
Developing a novel antibiotic for bacterial pneumonia.
Developing a novel antibiotic for bacterial pneumonia.
more
Company Data
Headquarters Vienna, , Austria
Founded 2005
Employees 41
Website www.nabriva.com
 

Performance vs. IPO Index (IPOUSA)